Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 24, 2017

DrugPatentWatch Database Preview

CEFUROXIME AXETIL Drug Profile

« Back to Dashboard

Which patents cover Cefuroxime Axetil, and when can generics launch?

Cefuroxime Axetil is a drug marketed by Aurobindo Pharma Ltd, Sun Pharm Inds Ltd, Sandoz, Lupin, Ranbaxy Labs Ltd, Orchid Hlthcare, Wockhardt, Apotex, Ani Pharms Inc, and Alkem Labs Ltd. and is included in eleven NDAs.

The generic ingredient in CEFUROXIME AXETIL is cefuroxime axetil. There are sixty-one drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the cefuroxime axetil profile page.

Summary for Tradename: CEFUROXIME AXETIL

Patents:0
Applicants:10
NDAs:11
Suppliers / Packagers: see list26
Bulk Api Vendors: see list40
Clinical Trials: see list10
Patent Applications: see list1,497
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CEFUROXIME AXETIL at DailyMed

Pharmacology for Tradename: CEFUROXIME AXETIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065308-001Mar 29, 2006ABRXNoNo► Subscribe► Subscribe
Orchid Hlthcare
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065359-003Feb 15, 2008ABRXNoNo► Subscribe► Subscribe
Ani Pharms Inc
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065190-001Oct 18, 2004ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
CEFUROXIME AXETIL
cefuroxime axetil
FOR SUSPENSION;ORAL065323-001Feb 5, 2008DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065118-001Apr 25, 2003DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot